Key result
SSRIs linked to abnormal coagulation and increased bleeding in some patients.
Why the study?
Despite the overall favorable safety profile of SSRIs, their use has been associated with abnormal coagulation and homeostasis, with resultant increased bleeding in some patients.
Do selective serotonin reuptake inhibitors (SSRIs) increase bleeding events?
Do selective serotonin reuptake inhibitors (SSRIs) increase bleeding events?
SSRIs have been associated with abnormal coagulation and increased bleeding in some patients.
Despite the overall favorable safety profile of selective serotonin reuptake inhibitors (SSRIs), their use has been associated with abnormal coagulation and homeostasis, with resultant increased bleeding in some patients (Meijer et al., 2004).
No takes yet. Share an insight, caveat, or question.
Y. W. Francis Lam (2026) studied this question. Selective serotonin reuptake inhibitors are associated with abnormal coagulation and increased bleeding in some patients.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: